HOLX vs TMO · P/E 32, rev $4.10B vs P/E 24, rev $44.56B
Hologic Inc (HOLX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the HOLX and TMO stock pages for the full models.
Not investment advice.